Business Standard

Dr Reddy's Lab rises 2.3%

Related News

The stock jumped 2.3 per cent to Rs 1,204.55 after the company said Phase-III clinical trial for its anti-diabetic molecule balaglitazone achieved the set parameters.

The company which conducted the study to determine the efficacy and safety of the drug, with Rheoscience — a subsidiary of said, it met its primary endpoint of reducing HbA1c or Glycoslated haemoglobin molecule, which indicates glucose level in blood. Besides, the oral anti-diabetic drug also showed effective results on fasting plasma glucose, oedeman and weight gain & body composition.

Read more on:   
|

Dr Reddy's Lab rises 2.3%

The stock jumped 2.3 per cent to Rs 1,204.55 after the company said Phase-III clinical trial for its anti-diabetic molecule balaglitazone achieved the set parameters.

The stock jumped 2.3 per cent to Rs 1,204.55 after the company said Phase-III clinical trial for its anti-diabetic molecule balaglitazone achieved the set parameters.

The company which conducted the study to determine the efficacy and safety of the drug, with Rheoscience — a subsidiary of said, it met its primary endpoint of reducing HbA1c or Glycoslated haemoglobin molecule, which indicates glucose level in blood. Besides, the oral anti-diabetic drug also showed effective results on fasting plasma glucose, oedeman and weight gain & body composition.

image

Recommended for you

Advertisements

Quick Links

Market News

Speculators fuelling soybean prices: SOPA

SOPA blamed the futures market for underestimating the crop size, which it said has pushed up prices 20% in a month. Soybean prices are trading ...

Gold cuts losses as dollar pauses; focus on US jobs data

Spot gold fell initially then rebounded 0.3 per cent to $1,191 an ounce by 1143 GMT

Today's picks- 5 May 2015

Nifty, Bank Nifty, Tata Steel, Mahindra & Mahindra & Coal India

Cipla promoter family gets Sebi go-ahead for voting agreement

In a possible succession planning exercise, pharma giant Cipla's promoter family has proposed to vote together as a single unit under overall ...

SAT adjourns Irdai appeal to July

Lawyers seek time to file replies

 

Back to Top